Skip to content

Company

InflammaSense

Description

Headquarters
US

Structure of InflammaSense

InflammaSense

Company

3 connections
OwnershipInvestment and holdings
UpstreamSupply and dependency
ConstraintsRegulation and exposure
Relationship began2026
InflammaSenseCompany · 3 connections
Layer 1

UpstreamSupply and dependency1

OwnershipInvestment and holdings1

ConstraintsRegulation and exposure1

Relations

Arrows show the direction of the relationship. Filter to focus on a business area.

  • InflammaSensepart of →CIRCLE program
    Fact90%
    View evidence
    • CompanyPR Newswire news releases2026-10-07 18:00
      InflammaSense joins the program as a subaward performer under prime awardee the University of Vermont, working alongside UVM's Gary An on the ReSCUED effort within CIRCLE.
      View source
  • Fact90%
    View evidence
    • CompanyPR Newswire news releases2026-10-07 18:00
      InflammaSense, Inc., a pre-revenue medtech company developing wearable autonomic neurography (ANG) technology
      View source
  • InflammaSenselocated in →La Jolla, California
    Fact90%
    View evidence
    • CompanyPR Newswire news releases2026-10-07 18:00
      InflammaSense is a pre-revenue medtech company based in La Jolla, California, developing autonomic neurography (ANG) technology for real-time immune monitoring.
      View source

Showing 1 to 3 of 3

Claims

Read the assertion alongside its sources. Expand a row to inspect the evidence.

FactEvidence 1

InflammaSense is a pre-revenue medtech company based in La Jolla, California, developing autonomic neurography (ANG) technology for real-time immune monitoring.

PR Newswire news releases · 2026-10-07 18:00

View evidence
  • CompanyPR Newswire news releases2026-10-07 18:00
    InflammaSense is a pre-revenue medtech company based in La Jolla, California, developing autonomic neurography (ANG) technology for real-time immune monitoring.
    View source
FactEvidence 1

InflammaSense joins the program as a subaward performer under prime awardee the University of Vermont, working alongside UVM's Gary An on the ReSCUED effort within CIRCLE.

PR Newswire news releases · 2026-10-07 18:00

View evidence
  • CompanyPR Newswire news releases2026-10-07 18:00
    InflammaSense joins the program as a subaward performer under prime awardee the University of Vermont, working alongside UVM's Gary An on the ReSCUED effort within CIRCLE.
    View source
FactEvidence 1

InflammaSense, Inc., a pre-revenue medtech company developing wearable autonomic neurography (ANG) technology

PR Newswire news releases · 2026-10-07 18:00

View evidence
  • CompanyPR Newswire news releases2026-10-07 18:00
    InflammaSense, Inc., a pre-revenue medtech company developing wearable autonomic neurography (ANG) technology
    View source

Showing 1 to 3 of 3

Market and valuation

Valuation data is available on Pro and Research.

Included in Pro

Not available: Company signals · Financials · Filings · Guidance